Confirmed Control (3%) Closed Deal verified CPGSkincareSupplementsVitaminsVitamins & SupplementsWellness Products
Swisse acquired by Biostime
Biostime acquired Swisse, an Australian vitamins & supplements brand on Sep 17, 2015. The transaction value is shown as USD 1.7bn. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Swisse
- Acquirer
- Biostime
- Seller
- -
- Announced
- 2015-09-17
- Geography
- Australia
- Tags
- CPGSkincareSupplementsVitaminsVitamins & SupplementsWellness Products
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- 3%
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
$1.7B
Consideration | USD
Basis: Public source
EV / revenue
-
unknown
Basis: FundComb estimate
EV / EBITDA
15.5x
Basis: FundComb estimate
Basis
- USD 1.7bn consideration is treated as publicly disclosed or derived directly from public source data.
- EV / EBITDA is shown as 15.5x based on the available comp inputs.
- EBITDA and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
Source summary
No public source summary has been published for this transaction yet.